MétaCan
Menu
← Back to cohort

Comparison of first-line fingolimod efficacy compared with first-line interferon-beta or glatiramer therapy in MS patients with active disease using propensity-matched registry data (P3.247)

2015· article· en· W631190283 on OpenAlexaff
Tim Spelman, Niklas Bergvall, Guillermo Izquierdo, Raed Alroughani, Pamela McCombe, R. Fernandez Bolanos, Dana Horáková, Eva Havrdová, Celia Oreja‐Guevara, Jeannette Lechner‐Scott, Mark Slee, María Trojano, Helmut Butzkueven

Bibliographic record

VenueNeurology · 2015
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsOptech (Canada)
Fundersnot available
KeywordsFingolimodGlatiramer acetateMultiple sclerosisMedicineInterferon betaInternal medicinePropensity score matchingOncologyInterferon beta-1aBETA (programming language)Immunology

Abstract

fetched live from OpenAlex

OBJECTIVE: Investigate time to relapse and discontinuation in a propensity-matched sample of MS patients on first-line fingolimod compared with first line interferon-beta (IFNβ) or glatiramer acetate (GA) following relapse. BACKGROUND: Outcomes in patients initiating first-line fingolimod relative to IFNβ or GA following relapse are not known. Comparisons of treatment effectiveness from observational registry data can be confounded as treatment assignments are non-random. Propensity score matching is a statistical technique to adjust for covariate imbalances across cohorts. DESIGN/METHODS: The MSBase study is a global, longitudinal registry for Multiple Sclerosis. At time of data extraction, the registry contained 31,429 patients from 104 centres across 30 countries. All patients included in the analysis had at least one relapse in the 12 months prior to baseline. First line fingolimod initiations were 1:1 propensity matched to first-line IFNβ/GA commencements using sex, age, country, disease duration, EDSS and pre-treatment relapse activity as baseline matching characteristics. Predictors of time to first relapse and time to treatment discontinuation were investigated using a clustered marginal Cox model. RESULTS: A total of 180 first-line fingolimod patients were successfully matched to 180 IFNβ/GA commencements. Relapse rate in first line fingolimod was 18.4 relapse per 100 person-years (95[percnt] CI 13.8-24.7) compared with 25.1 relapse per 100 person-years with first-line IFNβ/GA (95[percnt] CI 20.8, 30.2). First line fingolimod was associated with a 46[percnt] reduction in the rate of on-treatment relapse compared with first-line IFNβ/GA (HR 0.54, 95[percnt] CI 0.35-0.83). Similarly first-line fingolimod was associated with a 42[percnt] reduction in treatment discontinuation compared with IFNβ/GA (HR 0.58, 95[percnt] CI 0.34, 0.96). The restricted sample size did not permit meaningful comparisons of confirmed disability progression. CONCLUSIONS: The efficacy of fingolimod initiation, as assessed by time to first relapse and treatment discontinuation, was superior to that of IFNβ/GA in a first-line setting in propensity-matched MS patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.053

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.017
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.273
GPT teacher head0.397
Teacher spread0.123 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeurology→Same topicMultiple Sclerosis Research Studies→French-language works237,207→